Job Watch
Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation
Notice NOT-MD-21-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
SRG: Data Analyst - Science
Excellent Benefits:
SRG:
Analysis of NGS data throughout the research and development of novel molecular diagnostic instruments.
London, England
Categories: Job Watch
UPDATE Implementation of Requirement to Submit the Federal Financial Report (FFR) in the Payment Management System
Notice NOT-OD-21-060 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend the Expiration Date for PA-18-590 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
Notice NOT-OD-21-054 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
We paused our Ph.D. research to lead a COVID-19 contact tracing team. Here’s what we learned
Graduate training prepares students for much more than research, these Ph.D. students write
Categories: Job Watch
High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed)
Funding Opportunity RFA-DA-22-006 from the NIH Guide for Grants and Contracts. This FOA will support high-throughput screening or similar transformative approaches to identify novel receptors, signal transducers, or small molecules that modulate SUD-relevant signal transduction pathways (dopamine, opioid, cannabinoid, nicotinic, or other appropriately justified pathway). These projects may also include secondary screens and/or validation of key hits identified.
Categories: Job Watch, Literature Watch
Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required)
Funding Opportunity RFA-AG-22-011 from the NIH Guide for Grants and Contracts. NIA invites applications for Phase 1, 2a, and 2b clinical trials of new compounds or re-purposed existing drugs, biologics (except stem cells), or supplements to treat multiple chronic conditions by modulating fundamental aging-related mechanisms as well as to test compounds that could affect the individual diseases and conditions disproportionally affecting older adults. This FOA is not intended to provide support for definitive efficacy and safety trials.
Categories: Job Watch, Literature Watch
Notice to Extend the Expiration Date for PAR-19-222, "Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)"
Notice NOT-DK-21-011 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
Funding Opportunity PA-21-158 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.
Categories: Job Watch, Literature Watch
Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)
Funding Opportunity RFA-TR-21-009 from the NIH Guide for Grants and Contracts. This FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e. scents or odors) emanating from skin and to develop a catalog of VOCs as distinct signatures for at least 20 human diseases and conditions. These sensing devices must be able to associate VOC patterns using artificial intelligence to patients with various conditions for diagnostic purposes along with capabilities to incorporate and integrate vital signs. For VOC monitoring, these sensing devices can be Electronic-nose (E-nose) technology, Gas Chromatography (GC) or any sensing technology able to detect VOC patterns associated with disease. This new program is called SCENT, which stands for Screening for Conditions by E-Nose Technology. To ensure project success, this FOA requires multidisciplinary collaborations and a team science approach. Groups may include a combination of the following: Biomedical engineers, material scientists, biosensing experts, software engineers, chemists, clinicians, clinical trialists, biostatisticians, data analysts and/or other relevant experts in academia and industry.
Categories: Job Watch, Literature Watch
Request for Information (RFI): Use of Common Data Elements (CDEs) in NIH-funded research
Notice NOT-LM-21-005 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
Notice NOT-DA-21-018 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control
Notice NOT-CA-21-033 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
Notice NOT-TR-21-017 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Information (RFI): Screening for High Resolution Cryo-Electron Microscopy
Notice NOT-RM-21-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
What we’ve learned from communicating our science during the pandemic
"Feel free to speak passionately about why the science matters to you," our Letters to Young Scientists columnists write
Categories: Job Watch
Paramount Recruitment: Scientific Software Developer
Negotiable:
Paramount Recruitment:
Scientific Software Developer
Paramount have partnered with a major new start up in Oxford that has made exceptional progress in the field of canc
Homeworking
Categories: Job Watch
How to showcase your department to prospective grad students—virtually
Virtual “visits” can provide valuable insight—as long as they’re planned strategically
Categories: Job Watch
EMBL: Head of Human Resources, EMBL-EBI
Competitive Salary:
EMBL:
Head of Human Resources, EMBL-EBI
Location:
Cambridge, Cambridgeshire, England
Categories: Job Watch
Notice of Change to Key Dates for PA-18-623 "Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed)"
Notice NOT-NS-21-028 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Pages
